Literature DB >> 21071098

Psychosocial dwarfism: psychopathological aspects and putative neuroendocrine markers.

Antonio Muñoz-Hoyos1, Antonio Molina-Carballo, Maríadelcarmen Augustin-Morales, Francisco Contreras-Chova, Ana Naranjo-Gómez, Fuensanta Justicia-Martínez, José Uberos.   

Abstract

There exists an extensive terminology for defining the situation of children who, in varying circumstances, suffer from affective deprivation (AD), within an unsatisfactory family situation or in institutions. Nevertheless, the neuroendocrine mechanisms (if they exist) determining it have yet to be identified. Our objective was to determine if specific neuroendocrine markers, all of them previously implicated in affective disorders, could be modified, and in which sense, in affective deprivation syndrome of the child. For this purpose, we studied three separate groups of children: (1) control group (CG); (2) children suffering from AD; and (3) children with non-organic failure to thrive (NOFT). In every case, we studied the serum levels of melatonin, serotonin, β-endorphins and adrenocorticotropic hormone (ACTH); and kynurenine pathway tryptophan metabolites (both during the day and at night). Significantly, there was a conspicuous reduction in the levels of each of the neuroendocrine markers (melatonin, serotonin, β-endorphins and ACTH) in the group suffering from affective deficiency, a diminution which was even more noticeable in the group of patients presenting delayed growth. Furthermore, as also occurs in other affective disorders, there were corresponding modifications in the metabolisation of tryptophan. We report the existence of neuroendocrine mechanisms that are associated with the above-mentioned clinical manifestations in these patients, mechanisms that may underlie the close connection existing between AD syndrome and the cause of NOFT. These data suggest that the AD syndrome and NOFT comprise a single process, but one with a different evolutionary continuum of psychosocial dwarfism.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071098     DOI: 10.1016/j.psychres.2010.10.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  Breastfeeding Challenges and the Preterm Mother-Infant Dyad: A Conceptual Model.

Authors:  Chantal Lau
Journal:  Breastfeed Med       Date:  2017-10-19       Impact factor: 1.817

2.  BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology.

Authors:  Isabel Cubero-Millán; María-José Ruiz-Ramos; Antonio Molina-Carballo; Sylvia Martínez-Serrano; Luisa Fernández-López; Irene Machado-Casas; Pilar Tortosa-Pinto; Aida Ruiz-López; Juan-de-Dios Luna-Del-Castillo; José Uberos; Antonio Muñoz-Hoyos
Journal:  Psychopharmacology (Berl)       Date:  2016-11-03       Impact factor: 4.530

Review 3.  Change of pace: How developmental tempo varies to accommodate failed provision of early needs.

Authors:  Danielle Roubinov; Michael J Meaney; W Thomas Boyce
Journal:  Neurosci Biobehav Rev       Date:  2021-09-20       Impact factor: 8.989

4.  Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.

Authors:  Antonio Molina-Carballo; Fuensanta Justicia-Martínez; Francisco Moreno-Madrid; Isabel Cubero-Millán; Irene Machado-Casas; Laura Moreno-García; Josefa León; Juan-de-Dios Luna-Del-Castillo; José Uberos; Antonio Muñoz-Hoyos
Journal:  Psychopharmacology (Berl)       Date:  2014-03-06       Impact factor: 4.530

5.  Stress and hormones.

Authors:  Salam Ranabir; K Reetu
Journal:  Indian J Endocrinol Metab       Date:  2011-01

6.  Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.

Authors:  Isabel Cubero-Millán; Antonio Molina-Carballo; Irene Machado-Casas; Luisa Fernández-López; Sylvia Martínez-Serrano; Pilar Tortosa-Pinto; Aida Ruiz-López; Juan-de-Dios Luna-del-Castillo; José Uberos; Antonio Muñoz-Hoyos
Journal:  Int J Mol Sci       Date:  2014-09-25       Impact factor: 5.923

7.  Deep data science to prevent and treat growth faltering in Maya children.

Authors:  M I Varela-Silva; B Bogin; J A G Sobral; F Dickinson; S Monserrat-Revillo
Journal:  Eur J Clin Nutr       Date:  2016-04-20       Impact factor: 4.016

8.  A Translational Model of Incomplete Catch-Up Growth: Early-Life Hypoxia and the Effect of Physical Activity.

Authors:  Shlomit Radom-Aizik; Frank P Zaldivar; Dwight M Nance; Fadia Haddad; Dan M Cooper; Gregory R Adams
Journal:  Clin Transl Sci       Date:  2018-03-30       Impact factor: 4.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.